You are here

  • Home
  • Archive
  • Volume 6, Issue 3
  • Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma

Article Text

Article menu
Download PDFPDF
Treatment
Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma

https://doi.org/10.1136/ebn.6.3.76

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Walters EH, Walters JA, Gibson PW.Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.Cochrane Database Syst Rev2002;(4):CD003901(latest version 24 Apr 2002)

    QUESTION: What is the effectiveness of regular inhaled long acting β2 agonists compared with inhaled short acting β2 agonists in adults and children with chronic asthma?

    Data sources

    Studies were identified using the Cochrane Airways Review Group register, which is derived from searching Medline, CINAHL, and EMBASE/Excerpta Medica. In addition, bibliographies of relevant studies were scanned, key respiratory care journals were hand searched, and experts were contacted.

    Study selection

    Randomised controlled trials of ≥2 weeks duration were selected if they compared a regular inhaled long acting β2 agonist with a regular inhaled short …

    View Full Text

    Footnotes

    • Source of funding: Commonwealth Department of Health and Aged.

    • For correspondence: Professor E H Walters, Clinical School, University of Tasmania, Hobart, Tasmania, Australia.Haydn.Walters{at}utas.edu.au